Overview

Breast Cancer Tumor Care Observational Programme

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anastrozole